Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity

Clinical trial NCT05492318 · COMPLETED

Trial details

NCT number: NCT05492318
Sponsor: Italfarmaco
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug-Drug Interaction Heathy Volunteer

Start date: 2022-03-21
Primary completion: 2022-05-08
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.